244 related articles for article (PubMed ID: 2109748)
1. Decreases of the susceptibility to low molecular weight beta-lactam antibiotics in imipenem-resistant Pseudomonas aeruginosa mutants: role of outer membrane protein D2 in their diffusion.
Gotoh N; Nishino T
J Antimicrob Chemother; 1990 Feb; 25(2):191-8. PubMed ID: 2109748
[TBL] [Abstract][Full Text] [Related]
2. Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa.
Trias J; Nikaido H
Antimicrob Agents Chemother; 1990 Jan; 34(1):52-7. PubMed ID: 2109575
[TBL] [Abstract][Full Text] [Related]
3. Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay.
Okamoto K; Gotoh N; Nishino T
Antimicrob Agents Chemother; 2001 Jul; 45(7):1964-71. PubMed ID: 11408209
[TBL] [Abstract][Full Text] [Related]
4. Imipenem and meropenem induced resistance to beta-lactam antibiotics in Pseudomonas aeruginosa.
Giacometti A; Siquini FM; Cirioni O; Petroni S; Scalise G
Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):315-8. PubMed ID: 8070438
[TBL] [Abstract][Full Text] [Related]
5. Potency of carbapenems for the prevention of carbapenem-resistant mutants of Pseudomonas aeruginosa: the high potency of a new carbapenem doripenem.
Sakyo S; Tomita H; Tanimoto K; Fujimoto S; Ike Y
J Antibiot (Tokyo); 2006 Apr; 59(4):220-8. PubMed ID: 16830889
[TBL] [Abstract][Full Text] [Related]
6. Emergence of cross-resistance to imipenem and other beta-lactam antibiotics in Pseudomonas aeruginosa during therapy.
Pagani L; Landini P; Luzzaro F; Debiaggi M; Romero E
Microbiologica; 1990 Jan; 13(1):43-53. PubMed ID: 2155376
[TBL] [Abstract][Full Text] [Related]
7. Diffusion of beta-lactam antibiotics through liposome membranes reconstituted from purified porins of the outer membrane of Pseudomonas aeruginosa.
Satake S; Yoshihara E; Nakae T
Antimicrob Agents Chemother; 1990 May; 34(5):685-90. PubMed ID: 2163239
[TBL] [Abstract][Full Text] [Related]
8. Comparative activity of meropenem against Pseudomonas aeruginosa strains with well-characterized resistance mechanisms.
Livermore DM; Yang YJ
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():149-59. PubMed ID: 2553657
[TBL] [Abstract][Full Text] [Related]
9. Lack of additive effect between mechanisms of resistance to carbapenems and other beta-lactam agents in Pseudomonas aeruginosa.
Dib C; Trias J; Jarlier V
Eur J Clin Microbiol Infect Dis; 1995 Nov; 14(11):979-86. PubMed ID: 8654449
[TBL] [Abstract][Full Text] [Related]
10. Role of cephalosporinase in carbapenem resistance of clinical isolates of Pseudomonas aeruginosa.
Zhou XY; Kitzis MD; Gutmann L
Antimicrob Agents Chemother; 1993 Jun; 37(6):1387-9. PubMed ID: 8328794
[TBL] [Abstract][Full Text] [Related]
11. Diffusion of beta-lactam antibiotics into proteoliposomes reconstituted with outer membranes of isogenic imipenem-susceptible and -resistant strains of Enterobacter cloacae.
Lee EH; Collatz E; Trias J; Gutmann L
J Gen Microbiol; 1992 Nov; 138(11):2347-51. PubMed ID: 1336033
[TBL] [Abstract][Full Text] [Related]
12. Detection of drug-resistance mechanism of Pseudomonas aeruginosa developing from a sensitive strain to a persister during carbapenem treatment.
Shen JL; Fang YP
Genet Mol Res; 2015 Jun; 14(2):6723-32. PubMed ID: 26125881
[TBL] [Abstract][Full Text] [Related]
13. Emergence of resistance to carbapenem antibiotics in Pseudomonas aeruginosa.
Margaret BS; Drusano GL; Standiford HC
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():161-7. PubMed ID: 2509413
[TBL] [Abstract][Full Text] [Related]
14. Roles of porin and beta-lactamase in beta-lactam resistance of Pseudomonas aeruginosa.
Hancock RE; Woodruff WA
Rev Infect Dis; 1988; 10(4):770-5. PubMed ID: 2460909
[TBL] [Abstract][Full Text] [Related]
15. Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams.
Lerner SA; Quinn JP
Chemioterapia; 1985 Feb; 4(1):95-101. PubMed ID: 3921267
[TBL] [Abstract][Full Text] [Related]
16. [Study on antibiotics susceptibility and mechanism of carbapenem-resistance in clinical isolates of Pseudomonas aeruginosa].
Arita K; Daido K; Ohashi N; Nakamura K; Takeshima Y; Kohara T
Jpn J Antibiot; 1999 Jul; 52(7):491-6. PubMed ID: 10516928
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial Effects of β-Lactams on Imipenem-Resistant Ceftazidime-Susceptible Pseudomonas aeruginosa.
Wi YM; Choi JY; Lee JY; Kang CI; Chung DR; Peck KR; Song JH; Ko KS
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373200
[TBL] [Abstract][Full Text] [Related]
18. Permeability of the outer membrane of Moraxella catarrhalis for beta-lactam antibiotics.
Gotoh N; Tanaka S; Nishino T
J Antimicrob Chemother; 1992 Mar; 29(3):279-85. PubMed ID: 1592697
[TBL] [Abstract][Full Text] [Related]
19. [Characterization of imipenem resistance in Pseudomonas aeruginosa: decreased phenotypic expression of outer membrane proteins D1 and D2].
Cullmann W; Büscher KH; Opferkuch W
Immun Infekt; 1986 Nov; 14(6):227-9. PubMed ID: 3100427
[TBL] [Abstract][Full Text] [Related]
20. Collateral sensitivity between aminoglycosides and beta-lactam antibiotics depends on active proton pumps.
Azimi L; Rastegar Lari A
Microb Pathog; 2017 Nov; 112():122-125. PubMed ID: 28958949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
